CRVW · CareView Communications Inc
Substantial doubt about the company's ability to continue as a going concern.
“The Company's net losses and working capital deficit raise substantial doubt about the Company's ability to continue as a going concern through August 12, 2027.”View the 10-Q filed Aug 12, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2024-03-05 | EPSTEIN STEVEN B |
Director |
Award↑
Filing footnotes — Non-qualified stock option (right to buy) (Direct)
On each of March 5, 2025 and March 5, 2026, an aggregate of 51,877 shares vest. On March 5 , 2027, the remaining 51,876 shares vest. |
Non-qualified stock option (right to buy)
|
155,630 |
| 2024-03-05 | Wheeler L. Allen |
Director |
Award↑
Filing footnotes — Non-qualified stock option (right to buy) (Direct)
On each of March 5, 2025 and March 5, 2026, an aggregate of 51,877 shares vest. On March 5, 2027, the remaining 51,876 shares vest. |
Non-qualified stock option (right to buy)
|
155,630 |
| 2024-03-05 | WHITE DAVID RICHARD |
Director |
Award↑
Filing footnotes — Non-qualified stock option (right to buy) (Direct)
On each of March 5, 2025 and March 5, 2026, an aggregate of 51,877 shares vest. On March 5 , 2027, the remaining 51,876 shares vest. |
Non-qualified stock option (right to buy)
|
155,630 |
| 2024-03-05 | Thompson Jason T |
Director |
Award↑
Filing footnotes — Non-qualified stock option (right to buy) (Direct)
On each of March 5, 2025 and March 5, 2026, an aggregate of 51,877 shares vest. On March 5, 2027, the remaining 51,876 shares vest. |
Non-qualified stock option (right to buy)
|
155,630 |
| 2024-03-05 | McRee Sandra K |
Chief Operating Officer |
Award↑
Filing footnotes — Non-qualified stock option (right to buy) (Direct)
On each of March 5, 2025, March 5, 2026 and March 5, 2027, an aggregate of 2,967,371 shares vest. |
Non-qualified stock option (right to buy)
|
8,902,113 |
| 2024-03-05 | HIGGINS JAMES R |
Director |
Award↑
Filing footnotes — Non-qualified stock option (right to buy) (Direct)
On each of March 5, 2025 and March 5, 2026, an aggregate of 51,877 shares vest. On March 5 , 2027, the remaining 51,876 shares vest. |
Non-qualified stock option (right to buy)
|
155,630 |
| 2023-05-24 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment. |
Common Stock
(I)
|
86,515,000 |
| 2023-05-24 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment. |
Common Stock
(I)
|
86,515,000 |
| 2023-05-24 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↓
Filing footnotes — Senior Secured Convertible Note due 2023 (Indirect)
HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. |
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-05-24 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. |
Common Stock
(I)
|
93,485,000 |
| 2023-05-24 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↓
Filing footnotes — Senior Secured Convertible Note due 2023 (Indirect)
HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. |
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-05-24 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↓
Filing footnotes — Senior Secured Convertible Note due 2023 (Indirect)
HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment. |
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-05-24 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. |
Common Stock
(I)
|
93,485,000 |
| 2023-05-24 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↓
Filing footnotes — Senior Secured Convertible Note due 2023 (Indirect)
HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment. |
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | Johnson Steven G. |
Director, President/CEO |
Other↓
Filing footnotes — Replacement Note (Direct)
See footnote 1. The Replacement Note was convertible immediately after issuance. |
Replacement Note
|
1,750,000 |
| 2023-03-30 | Wheeler L. Allen |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On March 30, 2023, the Reporting Person converted a Replacement Note dated December 30, 2022 for $800,000 into 8,000,000 shares of the Company's Common Stock at a conversion price of $0.10 per share. |
Common Stock
|
800,000 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. |
Common Stock
(I)
|
93,485,000 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↑
|
Common Stock
(I)
|
7,000,000 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | McRee Sandra K |
Chief Operating Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
On March 30, 2023, the Reporting Persons converted a Replacement Note dated December 30, 2022 for $100,000 into 1,000,000 shares of the Company's Common Stock at a conversion price of $0.10 per share. The Reporting Person, through Sandra McRee IRA, converted a Replacement Note dated December 30, 2022 for $200,000 into 2,000,000 shares of the Company's Common Stock at a conversion price of $0.10 per share. |
Common Stock
|
1,000,000 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | EPSTEIN STEVEN B |
Director |
Other↓
Filing footnotes — Replacement Note (Indirect)
See footnote 1. The Replacement Note was convertible immediately after issuance. Shares held by Steven and Deborah L. Epstein. |
Replacement Note
(I)
|
0 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | Lightcap Jeffrey C |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On March 30, 2023, the Reporting Persons converted Replacement Notes dated December 30, 2022 for an aggregate of $1,750,000 into an aggregate of 17,500,000 shares of the Company's Common Stock at a conversion price of $0.10 per share. |
Common Stock
|
6,500,000 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. |
Common Stock
(I)
|
93,485,000 |
| 2023-03-30 | EPSTEIN STEVEN B |
Director |
Other↓
Filing footnotes — Replacement Note (Direct)
See footnote 1. The Replacement Note was convertible immediately after issuance. |
Replacement Note
|
0 |
| 2023-03-30 | Wheeler L. Allen |
Director |
Other↓
Filing footnotes — Replacement Note (Direct)
See footnote 1. The Replacement Note was convertible immediately after issuance. |
Replacement Note
|
0 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment. |
Common Stock
(I)
|
86,515,000 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↓
Filing footnotes — Senior Secured Convertible Note due 2023 (Indirect)
HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment. |
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | Thompson Jason T |
Director |
Other↓
Filing footnotes — Replacement Note (Indirect)
See footnote 1. The Replacement Note was convertible immediately after issuance. Shares held by Thompson Family Investments, LLC for which Mr. Thompson is the sole manager. |
Replacement Note
(I)
|
130,000 |
| 2023-03-30 | Lightcap Jeffrey C |
Director |
Convert↓
Filing footnotes — Common Stock (Indirect)
On March 30, 2023, the Reporting Persons converted Replacement Notes dated December 30, 2022 for an aggregate of $1,750,000 into an aggregate of 17,500,000 shares of the Company's Common Stock at a conversion price of $0.10 per share. Shares held by PENSCO Trust Company, LLC, not in corporate capacity but solely as Custodian for Individual Retirement Account of Jeffrey C. Lightcap. |
Common Stock
(I)
|
7,000,000 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↑
|
Common Stock
(I)
|
6,500,000 |
| 2023-03-30 | Lightcap Jeffrey C |
Director |
Other↓
Filing footnotes — Replacement Note (Indirect)
See footnote 1. The Replacement Note was convertible immediately after issuance. Shares held by PENSCO Trust Company, LLC, not in corporate capacity but solely as Custodian for Individual Retirement Account of Jeffrey C. Lightcap. |
Replacement Note
(I)
|
0 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | Thompson Jason T |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On March 30, 2023, the Reporting Person(s) converted Replacement Notes dated December 30, 2022 for $150,000 and $130,000, respectively, into 1,500,000 and 1,300,000 shares, respectively, of the Company's Common Stock at a conversion price of $0.10 per share. |
Common Stock
|
1,500,000 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | Thompson Jason T |
Director |
Other↓
Filing footnotes — Replacement Note (Direct)
See footnote 1. The Replacement Note was convertible immediately after issuance. |
Replacement Note
|
150,000 |
| 2023-03-30 | Johnson Steven G. |
Director, President/CEO |
Convert↑
Filing footnotes — Common Stock (Direct)
On March 30, 2023, the Reporting Person converted a Replacement Note dated December 30, 2022 for $1,750,000 into 17,500,000 shares of the Company's Common Stock at a conversion price of $0.10 per share. |
Common Stock
|
17,500,000 |
| 2023-03-30 | Lightcap Jeffrey C |
Director |
Other↓
Filing footnotes — Replacement Note (Direct)
See footnote 1. The Replacement Note was convertible immediately after issuance. |
Replacement Note
|
0 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↓
Filing footnotes — Senior Secured Convertible Note due 2023 (Indirect)
HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. |
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | EPSTEIN STEVEN B |
Director |
Convert↑
Filing footnotes — Common Stock (Indirect)
On March 30, 2023, the Reporting Person(s) converted Replacement Notes dated December 30, 2022 for $150,000 and $250,000, respectively, into 1,500,000 and 2,500,000 shares, respectively, of the Company's Common Stock at a conversion price of $0.10 per share. Shares held by Steven and Deborah L. Epstein. |
Common Stock
(I)
|
2,500,000 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↑
|
Common Stock
(I)
|
6,500,000 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | HIGGINS JAMES R |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
On March 30, 2023, the Reporting Person converted a Replacement Note dated December 30, 2022 for $1,200,000 into 12,000,000 shares of the Company's Common Stock at a conversion price of $0.10 per share. |
Common Stock
|
12,000,000 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↑
|
Common Stock
(I)
|
6,000,000 |
| 2023-03-30 | HealthCor Associates, LLC |
Director, 10% Owner |
Other↓
|
Senior Secured Convertible Note due 2023
(I)
|
0 |
| 2023-03-30 | HealthCor Management, L.P. |
Director, 10% Owner |
Other↑
Filing footnotes — Common Stock (Indirect)
HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment. |
Common Stock
(I)
|
86,515,000 |
| 2023-03-30 | McRee Sandra K |
Chief Operating Officer |
Other↓
Filing footnotes — Replacement Note (Indirect)
See footnote 1. The Replacement Note was convertible immediately after issuance. |
Replacement Note
(I)
|
0 |
| 2023-03-30 | Thompson Jason T |
Director |
Convert↑
Filing footnotes — Common Stock (Indirect)
On March 30, 2023, the Reporting Person(s) converted Replacement Notes dated December 30, 2022 for $150,000 and $130,000, respectively, into 1,500,000 and 1,300,000 shares, respectively, of the Company's Common Stock at a conversion price of $0.10 per share. Shares held by Thompson Family Investments, LLC for which Mr. Thompson is the sole manager. |
Common Stock
(I)
|
1,300,000 |